| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +347 | +14% | $0.000000 | 2,763 | 01 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $68,266 | -173 | -6.3% | $394.60 | 2,590 | 01 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +253 | +9.8% | $0.000000 | 2,843 | 01 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $49,720 | -126 | -4.4% | $394.60 | 2,717 | 01 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +361 | +13% | $0.000000 | 3,078 | 02 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $70,633 | -179 | -5.8% | $394.60 | 2,899 | 02 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +464 | +16% | $0.000000 | 3,363 | 03 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $91,153 | -231 | -6.9% | $394.60 | 3,132 | 03 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +500 | +16% | $0.000000 | 3,632 | 04 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $97,861 | -248 | -6.8% | $394.60 | 3,384 | 04 Sep 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Restricted Stock Units | Award | $0 | +2,003 | $0.000000 | 2,003 | 01 Sep 2023 | Bio-Rad A Common Stock | 2,003 | $0.000000 | Direct | F2, F3 | |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -347 | -25% | $0.000000 | 1,041 | 01 Sep 2023 | Bio-Rad A Common Stock | 347 | $0.000000 | Direct | F2, F4 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -253 | -33% | $0.000000 | 507 | 01 Sep 2023 | Bio-Rad A Common Stock | 253 | $0.000000 | Direct | F2, F5 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -361 | -50% | $0.000000 | 361 | 02 Sep 2023 | Bio-Rad A Common Stock | 361 | $0.000000 | Direct | F2, F6 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -464 | -50% | $0.000000 | 464 | 03 Sep 2023 | Bio-Rad A Common Stock | 464 | $0.000000 | Direct | F2, F7 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -500 | -100% | $0.000000* | 0 | 04 Sep 2023 | Bio-Rad A Common Stock | 500 | $0.000000 | Direct | F2, F8 |
| Id | Content |
|---|---|
| F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
| F3 | The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| F4 | On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F5 | On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F6 | On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F7 | On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
| F8 | On September 4, 2018, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |